81 related articles for article (PubMed ID: 2457657)
1. A randomized trial of etoposide + cisplatin versus vinblastine + bleomycin + cisplatin + cyclophosphamide + dactinomycin in patients with good-prognosis germ cell tumors.
Bosl GJ; Geller NL; Bajorin D; Leitner SP; Yagoda A; Golbey RB; Scher H; Vogelzang NJ; Auman J; Carey R
J Clin Oncol; 1988 Aug; 6(8):1231-8. PubMed ID: 2457657
[TBL] [Abstract][Full Text] [Related]
2. Curing metastatic testicular cancer.
Einhorn LH
Proc Natl Acad Sci U S A; 2002 Apr; 99(7):4592-5. PubMed ID: 11904381
[TBL] [Abstract][Full Text] [Related]
3. Chronic physical effects and health care utilization in long-term ovarian germ cell tumor survivors: a Gynecologic Oncology Group study.
Matei D; Miller AM; Monahan P; Gershenson D; Zhao Q; Cella D; Champion VL; Williams SD
J Clin Oncol; 2009 Sep; 27(25):4142-9. PubMed ID: 19636015
[TBL] [Abstract][Full Text] [Related]
4. A Review of Medicinal Plants of the Himalayas with Anti-Proliferative Activity for the Treatment of Various Cancers.
Regassa H; Sourirajan A; Kumar V; Pandey S; Kumar D; Dev K
Cancers (Basel); 2022 Aug; 14(16):. PubMed ID: 36010892
[TBL] [Abstract][Full Text] [Related]
5. Application of Approved Cisplatin Derivatives in Combination Therapy against Different Cancer Diseases.
Tsvetkova D; Ivanova S
Molecules; 2022 Apr; 27(8):. PubMed ID: 35458666
[TBL] [Abstract][Full Text] [Related]
6. Four Cycles of Etoposide plus Cisplatin for Patients with Good-Risk Advanced Germ Cell Tumors.
Funt SA; McHugh DJ; Tsai S; Knezevic A; O'Donnell D; Patil S; Silber D; Bromberg M; Carousso M; Reuter VE; Carver BS; Sheinfeld J; Motzer RJ; Bajorin DF; Bosl GJ; Feldman DR
Oncologist; 2021 Jun; 26(6):483-491. PubMed ID: 33586274
[TBL] [Abstract][Full Text] [Related]
7. Impact of Teratoma on the Cumulative Incidence of Disease-Related Death in Patients With Advanced Germ Cell Tumors.
Funt SA; Patil S; Feldman DR; Motzer RJ; Bajorin DF; Sheinfeld J; Tickoo SK; Reuter VE; Bosl GJ
J Clin Oncol; 2019 Sep; 37(26):2329-2337. PubMed ID: 31233353
[TBL] [Abstract][Full Text] [Related]
8. Early and late adverse renal effects after potentially nephrotoxic treatment for childhood cancer.
Kooijmans EC; Bökenkamp A; Tjahjadi NS; Tettero JM; van Dulmen-den Broeder E; van der Pal HJ; Veening MA
Cochrane Database Syst Rev; 2019 Mar; 3(3):CD008944. PubMed ID: 30855726
[TBL] [Abstract][Full Text] [Related]
9. Pineal germ cell tumors: Two cases with review of histopathologies and biomarkers.
Nagasawa DT; Lagman C; Sun M; Yew A; Chung LK; Lee SJ; Bui TT; Ooi YC; Robison RA; Zada G; Yang I
J Clin Neurosci; 2017 Apr; 38():23-31. PubMed ID: 28189312
[TBL] [Abstract][Full Text] [Related]
10. Chemotherapy for Good-Risk Nonseminomatous Germ Cell Tumors: Current Concepts and Controversies.
In G; Dorff T
Urol Clin North Am; 2015 Aug; 42(3):347-57. PubMed ID: 26216822
[TBL] [Abstract][Full Text] [Related]
11. Rates of teratoma and viable cancer at post-chemotherapy retroperitoneal lymph node dissection after induction chemotherapy for good risk nonseminomatous germ cell tumors.
Kundu SD; Feldman DR; Carver BS; Gupta A; Bosl GJ; Motzer RJ; Bajorin DF; Sheinfeld J
J Urol; 2015 Feb; 193(2):513-8. PubMed ID: 25150639
[TBL] [Abstract][Full Text] [Related]
12. A review of second-line chemotherapy and prognostic models for disseminated germ cell tumors.
Voss MH; Feldman DR; Bosl GJ; Motzer RJ
Hematol Oncol Clin North Am; 2011 Jun; 25(3):557-76, viii -ix. PubMed ID: 21570609
[TBL] [Abstract][Full Text] [Related]
13. Testicular cancer: seminoma.
Chung P; Warde P
BMJ Clin Evid; 2011 Jan; 2011():. PubMed ID: 21477387
[TBL] [Abstract][Full Text] [Related]
14. Canadian consensus guidelines for the management of testicular germ cell cancer.
Wood L; Kollmannsberger C; Jewett M; Chung P; Hotte S; O'Malley M; Sweet J; Anson-Cartwright L; Winquist E; North S; Tyldesley S; Sturgeon J; Gospodarowicz M; Segal R; Cheng T; Venner P; Moore M; Albers P; Huddart R; Nichols C; Warde P
Can Urol Assoc J; 2010 Apr; 4(2):e19-38. PubMed ID: 20368885
[No Abstract] [Full Text] [Related]
15. Identification and validation of a gene expression signature that predicts outcome in adult men with germ cell tumors.
Korkola JE; Houldsworth J; Feldman DR; Olshen AB; Qin LX; Patil S; Reuter VE; Bosl GJ; Chaganti RS
J Clin Oncol; 2009 Nov; 27(31):5240-7. PubMed ID: 19770384
[TBL] [Abstract][Full Text] [Related]
16. Good-risk-advanced germ cell tumors: historical perspective and current standards of care.
Feldman DR; Motzer RJ
World J Urol; 2009 Aug; 27(4):463-70. PubMed ID: 19513721
[TBL] [Abstract][Full Text] [Related]
17. Testicular cancer: seminoma.
Neal RD; Stuart N; Wilkinson C
BMJ Clin Evid; 2007 Feb; 2007():. PubMed ID: 19454048
[TBL] [Abstract][Full Text] [Related]
18. [Can systemic treatment for lymph node metastases be given with curative intent?].
Gauler T; Schuler M
Urologe A; 2009 Jan; 48(1):62-5. PubMed ID: 19050846
[TBL] [Abstract][Full Text] [Related]
19. A rare case of advanced testicular seminoma in a 78-year-old man managed successfully with carboplatin based chemotherapy: a case report.
Ismaili N; Naciri S; Afqir S; Mellas N; Bekkouch I; Elmajjaoui S; Masbah O; Othmani N; Flechon A; Droz JP; Errihani H
Cases J; 2008 Nov; 1(1):357. PubMed ID: 19040740
[TBL] [Abstract][Full Text] [Related]
20. Three cycles of etoposide and cisplatin chemotherapy in clinical stage IS nonseminomatous testicular cancer.
Mezvrishvili Z; Managadze L
Int Urol Nephrol; 2006; 38(3-4):621-4. PubMed ID: 17111082
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
